One of the outputs of the RISCC project is a Guidance Document.

Advancing Public Health: RISCC project contribution to the future of cervical cancer screening

Update: Many joined us for an exclusive webinar where leading researchers from the RISCC project share ground-breaking insights and solutions that are shaping the future of cervical cancer prevention.

You can watch the livestream here

REGISTER HERE (link no longer valid)

Cervical cancer screening is undergoing a major transformation, shifting from traditional cytology to advanced HPV testing in many countries. This change holds the promise of improved cancer detection but also poses challenges, such as managing increased positivity rates without escalating costs.

At the same …

RISCC at EUROGIN 2024

EUROGIN 2024- Innovations in HPV Research and Global Cancer Solutions: an International Collaborative Conference held at the Waterfront Congress Centre, in Stockholm, March 13-16, 2024, and RISCC had a dedicated session (SS 27: RISCC: Implementation of risk-based

cervical cancer screening in Europe_ Chair: Berkhof H. (Netherlands) • Elfström M. (Sweden)).

Program:

• Introduction (Berkhof H. (Netherlands) & Elfström M. (Sweden)
• Risk of precancer by current and previous screening test results (Berkhof H. (Netherlands))
• Risk of precancer in vaccinated cohorts (Lehtinen M. (Finland))
• Risk of precancer by genotyping results (Arbyn M. (Belgium))
• Model-based evaluation of risk-based screening (Baussano …